Almost everyone with a flaking scalp has tried an antifungal shampoo. Most of them will tell you it worked for a while and then stopped. That pattern is so consistent that people conclude the product lost its effect, or that their scalp adapted to it, or that they need something stronger.
None of those are usually true. In the trial that established this treatment, ketoconazole shampoo produced an excellent response in 88% of 575 patients with moderate to severe scalp seborrheic dermatitis. That is a very high number. The gap between that result and what happens in a real bathroom is almost entirely explained by three specific dosing errors, and every one of them is fixable this week.
Quick answer
Ketoconazole shampoo for scalp seborrheic dermatitis is used at 2%, twice weekly for two to four weeks, applied to a wet scalp and left in contact for three to five minutes before rinsing. After clearance it steps down to once weekly indefinitely rather than stopping. In the pivotal trial, weekly maintenance produced 19% relapse over six months against 47% on placebo. The three commonest errors are using a 1% product, rinsing too soon, and stopping when the scalp looks clear.
Why a shampoo is a strange way to deliver a drug
Think about what you are being asked to do. A chronic inflammatory condition on a hair-covered surface is being treated with a product that is, by design, rinsed off. Compare that to the face, where the same organism gets treated with a leave-on cream that sits on the skin for twelve hours.
Same yeast. Same disease process. On the scalp it gets perhaps forty seconds of exposure, and on the face it gets half a day. Then people are surprised the scalp is the part that keeps relapsing.
This is not an argument against shampoos. They are the correct vehicle for a hair-bearing surface and they have good trial evidence behind them. It is an argument for taking the dosing instructions seriously, because a rinse-off product has almost no margin for error.
Error one: the strength on the shelf is not the strength in the trial
This catches almost everybody. Many widely available antidandruff products contain 1% ketoconazole. The clinical trial data that gets quoted for this condition was generated with the 2% formulation, which in many countries is a pharmacy or prescription product.
The difference is not theoretical. In a randomised comparison of the two strengths in severe dandruff and scalp seborrheic dermatitis, 2% was significantly superior to 1% at both two and four weeks, for reduction in flaking and for measured Malassezia density, at p less than 0.001. At follow-up, the 2% group also trended toward fewer relapses.
So if you have been using an over-the-counter product faithfully and getting a partial result, the first question is not whether to change ingredient. It is whether you have ever used the studied concentration.
Error two: contact time
Read the instructions on almost any medicated shampoo and you will find a number: leave it on for three to five minutes before rinsing.
Nobody does this. In a normal shower, shampoo goes on and comes off inside a minute, because that is what shampoo has trained us to do for our entire lives. An antifungal that has been rinsed away has not delivered a dose, it has delivered a wash.
There is direct trial evidence that contact time is a real variable rather than a manufacturer’s caution. In a study of short-contact application on the scalp, five and ten minutes produced similar results while shorter application performed less well, and all active groups significantly outperformed vehicle. The implication is that contact time has both a floor you must clear and a plateau beyond which more does not help.
Two practical corrections. First, use a timer, because subjective estimates of three minutes in a hot shower are wildly optimistic. Second, apply it to the scalp, not the hair. The disease is on the skin. Part the hair, work the product down to the surface with fingertips, and cover the affected zones deliberately rather than piling lather on top of your head.
This is the same principle that governs every rinse-off or wipe-off treatment in this field. Our guide to Malassezia folliculitis treatment runs into the identical problem on the trunk, where inadequate contact time is routinely mistaken for treatment resistance.
Error three: stopping when it looks clear
This is the big one, and it is the one that produces the “it stopped working” story.
The pivotal trial had two phases. In the first, 575 patients used 2% ketoconazole shampoo twice weekly for two to four weeks, and 88% had an excellent response. Then 312 of those responders went into a six-month prophylaxis phase and were split three ways.
Weekly active shampoo produced 19% relapse. Alternating active with placebo produced 31%. Weekly placebo produced 47%.
Sit with that. Every one of those people had already cleared. The drug had already worked. The only thing that differed over the following six months was how often they kept using it, and that alone moved relapse from roughly one in five to nearly one in two.
Seborrheic dermatitis is not an infection you clear and finish with. Malassezia is a permanent resident of adult skin, and it recolonises from your own sebum the moment suppression stops. Clearance is not the finish line, it is the point at which maintenance begins.
Why the scalp relapses faster than the face
People often notice that facial seborrheic dermatitis settles down and stays settled, while the scalp keeps coming back on the same regimen. There are three structural reasons for that, and none of them are about willpower.
The scalp has the highest density of sebaceous glands anywhere on the body. It is the richest lipid source available, and lipid is what Malassezia harvests. Recolonisation after suppression is simply faster where the food supply is greatest.
Second, hair provides occlusion. It traps warmth and moisture against the skin and creates conditions that favour yeast growth in a way that exposed facial skin does not.
Third, and most importantly, the delivery is intermittent and brief. The face gets a leave-on product daily. The scalp gets a rinse-off product twice a week for a few minutes. Over a fortnight, that is a difference of many hours of drug contact versus a handful of minutes.
So the scalp is not being stubborn. It is being underdosed relative to the biology it is up against, which is exactly why the maintenance step is not optional there.
What to do about your hair
The most common reason people abandon a working regimen is not the scalp. It is the hair.
Medicated shampoos are formulated for the skin, not for hair cosmetics, and prolonged contact can leave hair feeling dry, rough or dull. That is a real complaint and there is a straightforward answer: apply the ketoconazole shampoo to the scalp for the timed contact period, rinse, then use your normal conditioner on the mid-lengths and ends only, keeping it off the scalp.
Two related points. Coloured or chemically treated hair tolerates this better than people expect, though it is reasonable to space treatment away from the colouring appointment. And if the scalp itself is stinging or burning during application, that is not the treatment working and it should not be pushed through. Burning on application points either to a compromised barrier or to a different diagnosis, and it warrants a review rather than persistence.
Make sure you are treating the right thing
A shampoo that does nothing after four weeks of correct dosing is telling you something useful. Response to an adequately dosed antifungal is close to expected when the diagnosis is right, so a flat result is information, not a reason to escalate.
Seborrheic dermatitis gives greasy, yellowish scale sitting between the hairs on a pink base, and it usually has company: the eyebrows, the nasolabial folds, behind the ears, sometimes the mid-chest.
Scalp psoriasis gives thicker silvery scale with a sharply demarcated border that often crosses the hairline onto the forehead. Antifungals do not resolve it.
Follicular scale is the one most often missed. Instead of lifting off between the hairs, it forms a collar wrapped around the individual shaft and travels upward as the hair grows. That pattern points toward mite involvement rather than yeast, and an antifungal shampoo will not address it, because antifungal actives are not acaricidal. Our clinical guide to Demodex on the scalp covers the assessment, and Demodex shampoo protocols covers what changes when the target is a mite rather than a yeast.
The two can also coexist, which is the scenario that produces years of partial responses. Treating one engine while the other runs gives you exactly the improve-then-plateau pattern people describe.
Alternatives and where they sit
Ketoconazole is not the only option with evidence. Ciclopirox, selenium sulfide and zinc pyrithione all have supportive data, and current European guidance treats topical azoles, selenium sulfide, ciclopirox and zinc pyrithione as reasonable first-line choices.
One nuance worth knowing: some reviews have noted higher relapse with selenium sulfide, with the proposed explanation that it may increase sebum secretion, which is the exact substrate the yeast harvests. If you are relapsing quickly on selenium sulfide, that is a reason to rotate rather than persist.
Topical corticosteroid shampoos work quickly on inflammation and have no antifungal action at all, which is why they are for short flare control rather than a standing routine. Non-steroidal anti-inflammatory options now exist for this condition too, and we cover the newest of them in our guide to roflumilast for seborrheic dermatitis, which acts on the host response instead of the organism.
For practitioners
Peter and Richarz-Barthauer (Br J Dermatol 1995;132:441-445) remains the anchor trial for scalp disease: n=575 for the treatment phase, twice weekly ketoconazole 2% for two to four weeks, 88% excellent response; n=312 into six-month prophylaxis with relapse of 19% (weekly active), 31% (alternating active and placebo) and 47% (weekly placebo). The dose-response across the three maintenance arms is the most clinically actionable finding in the seborrheic dermatitis literature and is routinely omitted from patient instructions.
Pierard-Franchimont et al. (2001) provides the concentration argument, with 2% superior to 1% for both squamometric flaking and Malassezia density at p<0.001, which matters because much OTC supply is 1%.
Practical counselling points that change adherence: specify a timed three to five minute contact period, direct application to scalp skin rather than hair, and set the maintenance expectation at the first visit rather than at first relapse. Where a patient reports adequate dosing with no response at four weeks, reconsider the diagnosis before escalating, with particular attention to follicular versus interfollicular scale distribution and to concurrent facial or lid-margin signs.
Frequently asked questions
How long should I leave ketoconazole shampoo on?
Three to five minutes, timed. Applied to a wet scalp, worked down to the skin rather than through the hair, then rinsed. Rinsing immediately is the commonest reason for a poor result.
Is 1% ketoconazole shampoo good enough?
It is better than nothing, but the trial evidence quoted for this condition used 2%, and a head-to-head comparison found 2% significantly better than 1% for both flaking and yeast density. If a 1% product is only partially working, that is worth discussing with a pharmacist or prescriber.
How often should I use it?
Twice weekly for two to four weeks to clear, then once weekly ongoing to maintain. The maintenance step is the one that determines whether it comes back.
Why does my scalp seborrheic dermatitis always return?
Malassezia is a normal resident of adult skin, not an invader you can eradicate. Treatment suppresses a population that then rebuilds from your own sebum. Recurrence after stopping is the expected behaviour of the condition, not a sign that treatment failed.
Can I use it every day?
Daily use is not what the trials tested and it is not usually necessary. Twice weekly with adequate contact time outperforms daily use with inadequate contact time.
What if it does not work at all?
Four weeks of correct dosing with no response is a reason to reconsider the diagnosis rather than to increase the dose. Scalp psoriasis, tinea capitis and mite-associated follicular disease all present with scale and all behave differently.
References
- Peter RU, Richarz-Barthauer U. Successful treatment and prophylaxis of scalp seborrhoeic dermatitis and dandruff with 2% ketoconazole shampoo: results of a multicentre, double-blind, placebo-controlled trial. British Journal of Dermatology, 1995;132(3):441-445. PMID 7718463.
- Pierard-Franchimont C, Goffin V, Decroix J, Pierard GE. A multicenter randomized trial of ketoconazole 2% and zinc pyrithione 1% shampoos in severe dandruff and seborrheic dermatitis. Skin Pharmacology and Applied Skin Physiology, 2002;15(6):434-441.
- Pierard-Franchimont C, et al. Effect of ketoconazole 1% and 2% shampoos on severe dandruff and seborrhoeic dermatitis: clinical, squamometric and mycological assessments. Dermatology, 2001. PMID 11306850.
- Reygagne P, Poncet M, Sidou F, Soto P. Clobetasol propionate shampoo 0.05% in the treatment of seborrheic dermatitis of the scalp: results of a pilot study. Cutis, 2007;79(5):397-403. PMID 17569404.
- Gupta AK, et al. Role of topical ketoconazole in therapeutic hair care beyond seborrhoeic dermatitis and dandruff. JEADV Clinical Practice, 2025.
- Henning MAS, Hay R, Rodriguez-Cerdeira C, et al. Position statement: recommendations on the diagnosis and treatment of Malassezia folliculitis. Journal of the European Academy of Dermatology and Venereology, 2023;37(7):1268-1275.
- DeAngelis YM, Gemmer CM, Kaczvinsky JR, et al. Three etiologic facets of dandruff and seborrheic dermatitis. Journal of Investigative Dermatology Symposium Proceedings, 2005;10(3):295-297.
- Karabay EA, Aksu Cerman A. Demodex folliculorum infestations in common facial dermatoses. Anais Brasileiros de Dermatologia, 2020. PMC7175027.
Selected sources: Peter and Richarz-Barthauer 1995 (PubMed) and the 1% versus 2% comparison (PubMed).
Flaking that never fully clears despite correct dosing? Take the symptom self-assessment to work through the discriminating features, or browse the full library of scalp and seborrheic dermatitis guides.
About the author. Marina Ivakhnenko is a functional skin practitioner focused on Demodex-associated and inflammatory skin conditions. This article is educational and is not a substitute for individual medical care. Ketoconazole 2% is a pharmacy or prescription product in many countries and should be used under appropriate guidance.